India has no plan to introduce a vaccine passport for global travel. Union MoS for External Affairs V Muraleedharan said this in a written reply to a question posed in Lok Sabha. He said no multilateral arrangements have been reached in this regard.

India gives CoWIN vaccine certificates to fully vaccinated persons. Some countries have rolled out a vaccine passport, a documentary proof that a person has been vaccinated used to fast track visa applications for travel. 

    

No plan to introduce vaccine passport for global travel: Ministry of External Affairs

WHAT?

India has no plan to introduce a vaccine passport, said Union MoS for External Affairs V Muraleedharan in a written reply to a question posed in Lok Sabha. He said no multilateral arrangements have been reached in this regard.    

MORE:

"India has been part of ongoing discussions to ensure that Indian manufactured vaccines are duly recognised in any multilateral arrangement. India is also engaging with countries for mutual recognition of vaccination certificates," Muraleedharan further added.

India gives CoWIN vaccine certificates to fully vaccinated persons. MEA Spokesperson Arindam Bagchi earlier said that India hoped that blocs like European Union will recognise the certificate for travel on a reciprocal basis. 

The 31-nation bloc launched its EU Digital Covid Certificate (EUCC) also known as 'Green Passport' to allow hassle-free intra-Europe travel for those who had taken one of the four jabs approved by the European Medicines Agency (EMA). While there is uncertainty over EMA's approval of India-manufactured Covishield, 15 European nations have accepted the same.  

In India, vaccination certificates are issued for COVID-19 vaccines which are approved for emergency use in India and to only such volunteers who participated in the trials for such vaccines. Currently, three vaccines are approved by the Drug Controller General of India (DCGI) for emergency use in India: Oxford-AstraZeneca's 'Covishield'  manufactured by Serum Institute of India, Bharat Biotech’s 'Covaxin', and the Russian Sputnik V.